BeOne Medicines (BEIGF) Change in Intangibles (2017 - 2025)

BeOne Medicines (BEIGF) reported Change in Intangibles of $20.0 million for Q2 2025, up 327.9% quarter-over-quarter from $4.7 million in Q1 2024.

BeOne Medicines (BEIGF) Change in Intangibles (2017 - 2025) Analysis & Trends

BeOne Medicines (BEIGF) has 5 years of Change in Intangibles data on file, last reported at $20.0 million in Q2 2025.

  • Change in Intangibles for Q2 2025 came in at $20.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $20.0 million (up 327.9% YoY), and the FY2025 annual result was $20.0 million, up 327.9% from the prior year.
  • Change in Intangibles grew to $20.0 million in Q2 2025 per BEIGF's latest filing, from $4.7 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $20.0 million in Q2 2025 and troughed at $4.7 million in Q1 2024.
  • A 3-year average of $11.0 million and a median of $9.7 million in 2023 frame the typical range for Change in Intangibles.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 821,726.73 Bn 821,726.69 Bn - -
2 Belite Bio 57,768.00 Bn 57,768.00 Bn - -
3 Quantum Biopharma 16,655.88 Bn 16,655.88 Bn - -2.96 Mn
4 Legend Biotech 3,540.00 Bn 3,539.71 Bn 242.10 Mn -
5 Evaxion A 1,526.26 Bn 1,526.24 Bn - -
6 Akari Therapeutics 1,520.09 Bn 1,520.09 Bn - -
7 Psyence Biomedical 223.87 Bn 223.87 Bn - -
8 Vertex Pharmaceuticals 114.47 Bn 107.23 Bn 2.59 Bn -
9 Abivax 91.22 Bn 91.22 Bn - -
10 BeOne Medicines - - 1.35 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 20.00 Mn
Jun 30, 2025 20.00 Mn
Mar 31, 2024 4.67 Mn
Mar 31, 2024 4.67 Mn
Dec 31, 2023 9.95 Mn
Dec 31, 2023 9.95 Mn
Sep 30, 2023 9.41 Mn
Sep 30, 2023 9.41 Mn
Dec 31, 2018 332,000.00
Dec 31, 2018 332,000.00
Sep 30, 2018 612,000.00
Sep 30, 2018 612,000.00
Sep 30, 2017 -12.12 Mn
Sep 30, 2017 -12.12 Mn